Quality of Life and Fixed-ratio Combination of Insulin Degludec and Liraglutide (iDegLira)
NCT04190160
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
35
Enrollment
OTHER
Sponsor class
Conditions
Type2 Diabetes
Interventions
DRUG:
IDegLira
Sponsor
Stefano Rizza